FDA Updates Saquinavir Labeling
“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir."
“Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.”
The updated labeling will be available at the FDA website.
More information is available:
Recent HIV/AIDS News from FDA and NIAID